Consistent information in product information and on OTC product labels are needed to clearly communicate the increased risk of miscarriage associated with all non-aspirin NSAIDs, a TGA review has concluded. The Pharmacovigilance and Special Access Branch found that the risk of miscarriage is discussed in Australian PI for only five of 14 non-aspirin NSAID molecules. ...
Better warnings needed over NSAID link to miscarriage
By Tony James
9 Oct 2016